Evaluation of the role of erythropoietin and methotrexate in multiple sclerosis

BACKGROUND: Erythropoietin, originally recognized for its role in erythropoiesis, has been shown to improve neurological outcome after stroke. Low-dose methotrexate is effective against certain inflammatory diseases, such as severe psoriasis and rheumatoid arthritis as well as Crohn's disease....

Descripción completa

Detalles Bibliográficos
Autores principales: Dasgupta, Sandipan, Mazumder, Bhaskar, Ramani, Y. Roja, Bhattacharyya, Subhra Prakash, Das, Mukesh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195118/
https://www.ncbi.nlm.nih.gov/pubmed/22021991
http://dx.doi.org/10.4103/0253-7613.84955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195118/
https://www.ncbi.nlm.nih.gov/pubmed/22021991
http://dx.doi.org/10.4103/0253-7613.84955

Ejemplares similares